SEC Form 4 research
| Issuer | Aardvark Therapeutics, Inc. |
|---|---|
| Tickers | AARD |
| Reporting owners | 17 |
| Officers and directors | 2 |
| Last public filing | 2026-10-08 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-10-08 | 2026-10-07 | Zhang Zhongwei | A | 127,061 | $0 | Not reported |
| 2026-09-11 | 2026-09-11 | Sun Nelson | S | 62,000 | $5.18 | Not reported |
| 2026-09-11 | 2026-09-10 | Sun Nelson | S | 14,754 | $5 | Not reported |
| 2026-08-21 | 2026-08-14 | Chi Jeffrey | A | 44,964 | $0 | Not reported |
| 2026-08-21 | 2026-08-14 | Graf Susan E | A | 44,964 | $0 | Not reported |
| 2026-08-21 | 2026-08-14 | Baynes Roy D. | A | 44,964 | $0 | Not reported |
| 2026-08-21 | 2026-08-14 | Tong Victor Edward Jr | A | 44,964 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.